BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 12669033)

  • 1. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
    Gill SS; Patel NK; Hotton GR; O'Sullivan K; McCarter R; Bunnage M; Brooks DJ; Svendsen CN; Heywood P
    Nat Med; 2003 May; 9(5):589-95. PubMed ID: 12669033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.
    Patel NK; Bunnage M; Plaha P; Svendsen CN; Heywood P; Gill SS
    Ann Neurol; 2005 Feb; 57(2):298-302. PubMed ID: 15668979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
    Ai Y; Markesbery W; Zhang Z; Grondin R; Elseberry D; Gerhardt GA; Gash DM
    J Comp Neurol; 2003 Jun; 461(2):250-61. PubMed ID: 12724841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor.
    Slevin JT; Gerhardt GA; Smith CD; Gash DM; Kryscio R; Young B
    J Neurosurg; 2005 Feb; 102(2):216-22. PubMed ID: 15739547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI volumetric and intensity analysis of the cerebellum in Parkinson's disease patients infused with glial-derived neurotrophic factor (GDNF).
    Chebrolu H; Slevin JT; Gash DA; Gerhardt GA; Young B; Given CA; Smith CD
    Exp Neurol; 2006 Apr; 198(2):450-6. PubMed ID: 16455079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal.
    Slevin JT; Gash DM; Smith CD; Gerhardt GA; Kryscio R; Chebrolu H; Walton A; Wagner R; Young AB
    J Neurosurg; 2007 Apr; 106(4):614-20. PubMed ID: 17432712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal.
    Slevin JT; Gash DM; Smith CD; Gerhardt GA; Kryscio R; Chebrolu H; Walton A; Wagner R; Young AB
    Neurosurg Focus; 2006 May; 20(5):E1. PubMed ID: 16711657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossroads in GDNF therapy for Parkinson's disease.
    Sherer TB; Fiske BK; Svendsen CN; Lang AE; Langston JW
    Mov Disord; 2006 Feb; 21(2):136-41. PubMed ID: 16470786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth factors as neuroprotective treatment in Parkinson disease?].
    Torp R; Singh PB; Sørensen DR; Dietrichs E; Hirschberg H
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):899-901. PubMed ID: 16554879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys.
    Zhang Z; Miyoshi Y; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1396-401. PubMed ID: 9316852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.
    Whone AL; Boca M; Luz M; Woolley M; Mooney L; Dharia S; Broadfoot J; Cronin D; Schroers C; Barua NU; Longpre L; Barclay CL; Boiko C; Johnson GA; Fibiger HC; Harrison R; Lewis O; Pritchard G; Howell M; Irving C; Johnson D; Kinch S; Marshall C; Lawrence AD; Blinder S; Sossi V; Stoessl AJ; Skinner P; Mohr E; Gill SS
    J Parkinsons Dis; 2019; 9(2):301-313. PubMed ID: 30829619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trophic factor distribution predicts functional recovery in parkinsonian monkeys.
    Gash DM; Zhang Z; Ai Y; Grondin R; Coffey R; Gerhardt GA
    Ann Neurol; 2005 Aug; 58(2):224-33. PubMed ID: 16049934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on Parkinson disease.
    Slevin JT; Gerhardt GA; Smith CD; Gash DM; Kryscio R; Young B
    J Neurosurg; 2005 Feb; 102(2):401. PubMed ID: 15739575
    [No Abstract]   [Full Text] [Related]  

  • 17. GDNF delivery for Parkinson's disease.
    Patel NK; Gill SS
    Acta Neurochir Suppl; 2007; 97(Pt 2):135-54. PubMed ID: 17691299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease.
    Lapchak PA; Gash DM; Collins F; Hilt D; Miller PJ; Araujo DM
    Exp Neurol; 1997 Jun; 145(2 Pt 1):309-21. PubMed ID: 9217068
    [No Abstract]   [Full Text] [Related]  

  • 19. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.